On June 2, 2026, FORWIT — Austria's Council for Research, Science, Innovation and Technology Development — published its funding recommendation for the "Fonds Zukunft Österreich" (FZÖ), allocating €75 million to strategic R&D initiatives for 2026. For tax advisors and CFOs operating across jurisdictions, understanding this framework unlocks a secondary capital layer beneath Austria's 14% R&D Tax Credit.
If you have clients with Austrian subsidiaries or R&D operations in the DACH region, there is a significant development worth understanding.
What Is the Fonds Zukunft Österreich?
The FZÖ is a direct grant program — distinct from the statutory R&D Tax Credit — administered through Austria's four main innovation agencies:
| Agency | Role | Allocation (FZÖ 2026) |
|---|---|---|
| FFG | Research Promotion Agency | € 32.0 M |
| FWF | Science Fund (basic research) | € 23.5 M |
| aws | Innovation financing | € 15.5 M |
| CDG | Christian Doppler Research Association | € 3.5 M |
| LBG | Ludwig Boltzmann Gesellschaft (clinical research) | € 6.5 M |
The budget was set at €75 million against €132.86 million in applications — a 77% oversubscription rate underscoring strong demand across Austria's innovation ecosystem.
Three Funding Lines
Line 1: EU Partnerships (€24.5 M)
Co-financing for Horizon Europe participants, covering quantum strategy, cybersecurity, LIFE, and raw materials partnerships. For clients whose Austrian entity participates in EU consortia, this funding directly reduces their net cost of European collaboration.
Line 2: Seals of Excellence (€14.0 M)
The Seal of Excellence is an EU quality label awarded to excellent proposals that could not be funded at the EU level. Austria uses this instrument to "rescue" top-rated projects — including ERC Starting Grants and EIC Accelerator projects — with national bridge funding. Many companies are unaware this option exists.
Line 3: Key Technology Infrastructures (€36.5 M)
The Austrian Quantum Cluster (AQC) receives the single largest allocation — €30 million with a 10-year horizon — bundling research, startups, and industry in quantum technologies and photonics. An additional €6.5 million funds Clinical Trials Austria.
How It Interacts with the 14% R&D Tax Credit
The strategic distinction for international advisors:
| Instrument | Type | Best For |
|---|---|---|
| R&D Tax Credit (14%) | Statutory, non-competitive | Baseline: all R&D-performing companies |
| FZÖ / FFG Grants | Competitive, strategic | High-tech, EU-oriented, deep-tech projects |
The R&D Tax Credit under § 108c EStG remains the foundational tool — automatic, non-competitive, covering 14% of qualifying R&D expenditure. The FZÖ programs are supplementary but can meaningfully increase total funding available to an Austrian R&D operation.
Strategic Takeaway for International Advisors
- Audit your client's Austrian R&D footprint against Austria's nine priority technology fields
- Check for Horizon Europe participation — co-financing from Line 1 reduces net EU costs
- Look for Seals of Excellence — bridge funding may be available without new applications
- Coordinate R&D Tax Credit and grant strategies — the FFG gutachten (expert opinion) for § 108c doubles as pre-qualification for grants
- Monitor the Quantum Cluster — €30 million over 10 years signals strategic priority
The Austrian R&D framework offers a rare combination: automatic tax credit baseline plus competitive grant overlay. For international capital allocators, this dual structure creates a compliance-efficient environment for locating R&D operations.
Source: FORWIT Recommendation, June 2, 2026 — DOI: 10.5281/zenodo.20429359